Single-agent therapy with vaccine or murine FAP-targeting CAR T cells had little effect on large E7-expressing subcutaneous lung cancer tumors, but the combination of these two treatments resulted in delayed tumor progression and significantly smaller tumor volume on day 21 post-tumor cell inoculation. Here, FAP is linked to lung carcinoma.